Pancreatic Cancer Research

ResearcherHospital Clínic de BarcelonaNo recent work listed

Eva Cristina Vaquero

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0098-5295; OpenAlex author ID A5009008481. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2016: 1 paper · 2017: 3 papers · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers

Papers 9

  1. Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology. Co-author DOI 10.3389/fmolb.2023.1161893↗
  2. Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. Co-author DOI 10.3390/cancers15061690↗
  3. HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer. Co-author DOI 10.15252/embj.2019102808↗
  4. DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth. Co-author DOI 10.1136/gutjnl-2018-316128↗
  5. Zeb1 in Stromal Myofibroblasts Promotes Kras-Driven Development of Pancreatic Cancer. Last author DOI 10.1158/0008-5472.can-17-1882↗
  6. Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies. Co-author DOI 10.1007/s12094-016-1609-7↗
  7. Erratum to: Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies. Co-author DOI 10.1007/s12094-017-1636-z↗
  8. Endoscopic ultrasonography can avoid unnecessary laparotomies in patients with pancreatic adenocarcinoma and undetected peritoneal carcinomatosis. Co-author DOI 10.1016/j.pan.2017.08.004↗
  9. [Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma]. Co-author DOI 10.1016/j.medcli.2016.07.033↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Glòria Fernández‐Esparrach · 4 shared papers, 2016–2023 · strength 0.41
  2. Àngels Ginés · 4 shared papers, 2016–2023 · strength 0.41
  3. Fabio Ausania · 2 shared papers, 2023 · strength 0.30
  4. Joan Maurel · 3 shared papers, 2016–2023 · strength 0.26
  5. Cristina Fillat · 2 shared papers, 2018–2019 · strength 0.17
  6. Leire Pedrosa · 1 shared paper, 2023 · strength 0.15
  7. Joan Llach · 1 shared paper, 2023 · strength 0.15
  8. Leticia Moreira · 1 shared paper, 2023 · strength 0.15
  9. Jorge Aparicio · 2 shared papers, 2017 · strength 0.12
  10. Ruth Vera · 2 shared papers, 2017 · strength 0.12
  11. Jeroni Luna · 1 shared paper, 2019 · strength 0.09
  12. Susana de la Luna · 1 shared paper, 2019 · strength 0.09
  13. Meritxell Gironella · 1 shared paper, 2019 · strength 0.09
  14. Mark Kalisz · 1 shared paper, 2020 · strength 0.09
  15. Lena Häberle · 1 shared paper, 2020 · strength 0.09
  16. Sami Alexander Safi · 1 shared paper, 2020 · strength 0.09
  17. Wolfram Trudo Knoefel · 1 shared paper, 2020 · strength 0.09
  18. Iréne Esposito · 1 shared paper, 2020 · strength 0.09
  19. Jorge P. Ferrer · 1 shared paper, 2020 · strength 0.09
  20. Francisco X. Real · 1 shared paper, 2020 · strength 0.09
  21. Maria Rovira-Rigau · 1 shared paper, 2018 · strength 0.08
  22. Irene Sangrador · 1 shared paper, 2018 · strength 0.08
  23. Nadia Alberghina · 1 shared paper, 2017 · strength 0.06
  24. Luis Sabater-Orti · 1 shared paper, 2016 · strength 0.05
  25. Marta Martín-Richard · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.